Amlisimod

N/A

Report date: 2026/03/09 20:02:04

Base Information

Drug NameAmlisimod
Drug Alias NameSDP-4
ClassificationBiologics
Mechanisms of ActionInhibitor of NF-kappa-B kinase (IKK) inhibitors
TargetsInhibitor of NF-kappa-B kinase (IKK)
Therapy Area/IndicationsXerophthalmia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSilk Technologies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSilk Technologies Ltd
Active IndicationsN/A
Inactive IndicationsXerophthalmia

Other Information

ATC CodeN/A
Related LinksN/A